Celanese Corp: Form 10-K for the period ended Dec 31, 2019
Filed with the SEC on Feb 6, 2020 and accepted by EDGAR at Feb 6, 2020, 21:24 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2019-12-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 12 months2019-01-01 to 2019-12-31 | $6.30bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 12 months2019-01-01 to 2019-12-31 | $4.69bn | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 12 months2019-01-01 to 2019-12-31 | $1.61bn | us-gaap:GrossProfit |
| Research and development | 12 months2019-01-01 to 2019-12-31 | $67.0m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 12 months2019-01-01 to 2019-12-31 | $483.0m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 12 months2019-01-01 to 2019-12-31 | $834.0m | us-gaap:OperatingIncomeLoss |
| Interest expense | 12 months2019-01-01 to 2019-12-31 | $115.0m | us-gaap:InterestExpense |
| Income tax | 12 months2019-01-01 to 2019-12-31 | $124.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 12 months2019-01-01 to 2019-12-31 | $852.0m | us-gaap:NetIncomeLoss |
| Diluted EPS | 12 months2019-01-01 to 2019-12-31 | $6.84 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 12 months2019-01-01 to 2019-12-31 | $6.88 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 12 months2019-01-01 to 2019-12-31 | 124,651,759 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 12 months2019-01-01 to 2019-12-31 | $1.45bn | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 12 months2019-01-01 to 2019-12-31 | $370.0m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 12 months2019-01-01 to 2019-12-31 | $300.0m | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 12 months2019-01-01 to 2019-12-31 | $996.0m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2019-12-31 | $463.0m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2019-12-31 | $2.77bn | us-gaap:AssetsCurrent |
| Total assets | At period end2019-12-31 | $9.48bn | us-gaap:Assets |
| Current liabilities | At period end2019-12-31 | $1.75bn | us-gaap:LiabilitiesCurrent |
| Long-term debt | At period end2019-12-31 | $3.41bn | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | At period end2019-12-31 | $496.0m | us-gaap:DebtCurrent |
| Shareholders' equity | At period end2019-12-31 | $2.51bn | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001306830-20-000018. Last ingested by Listed: Oct 24, 2026, 15:11 ET. Listed shows no prices and gives no investment advice.